Silva v. Secretary of Health & Human Services

108 Fed. Cl. 401, 2012 U.S. Claims LEXIS 1682, 2012 WL 6789066
CourtUnited States Court of Federal Claims
DecidedDecember 11, 2012
DocketNo. 10-101V
StatusPublished
Cited by207 cases

This text of 108 Fed. Cl. 401 (Silva v. Secretary of Health & Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Silva v. Secretary of Health & Human Services, 108 Fed. Cl. 401, 2012 U.S. Claims LEXIS 1682, 2012 WL 6789066 (uscfc 2012).

Opinion

Vaccine Act; Attorneys’ Fees; Reasonable Basis for Claim; HPV Vaccine; Transverse Myelitis v. Conversion Disorder

OPINION AND ORDER

HODGES, Judge.

Ms. Silva seeks attorneys’ fees for work on a petition for which compensation was not awarded. The special master denied compensation for failure of proof, and then denied attorneys’ fees because he found that the petition did not have a reasonable basis. The special master noted that no binding precedent guided his analysis of “reasonable basis,” but denied attorneys’ fees based on lack of support for the petition in the medical records. In his opinion, petitioner’s lawyers spent too little time reviewing those records before filing the petition.

Petitioner appealed the denial of fees, arguing that the special master took a stricter view of the reasonable basis standard than is justified by ease law developed pursuant to the Vaccine Act. Case láw in the Federal Circuit does not address how courts should interpret the Vaccine Act’s reasonable basis [402]*402standard, but the statute grants to the special master maximum discretion in applying the standard. For that reason, we reject petitioner’s appeal.

BACKGROUND

Petitioner alleged that the human papillo-mavirus, or HPV, vaccine caused her to suffer a neurological demyelinating injury.1 HPV vaccine injuries are not included in the Vaccine Injury Table, so petitioner had to show causation-in-fact to receive compensation. See 42 U.S.C. § 300aa-ll(c)(l)(C)(ii)(I).

Ms. Silva was fourteen years old when she received the HPV vaccine, first on January 11, and then on March 8, 2007. She sought treatment from her pediatrician numerous times for back pain and numbness in her legs, beginning in April of 2007. The pediatrician referred petitioner to a neurologist, who diagnosed Ms. Silva with transverse myelitis. He noted, however, that her “weakness in both lower extremities [and her] inability to walk appears to be secondary to depression.”

Another neurologist, Dr. Niesen, conducted a thorough evaluation of Ms. Silva over a seven-day period at Cedars-Sinai Medical Center in June 2007. Dr. Niesen diagnosed petitioner with a conversion disorder that excluded transverse myelitis as a factor.2 An October 2007 psychiatric evaluation ruled out conversion disorder and depression, but MRI studies of petitioner’s spine in 2008 and 2009, were negative for transverse myelitis. Thus, petitioner’s medical records contain diagnoses that could be considered conflicting on the question whether she suffered from transverse myelitis, a conversion disorder, or depression. Symptoms attributable to transverse myelitis might be compensable under the Vaccine Act, while similar physical limitations caused by a conversion disorder presumably would not be compensable. No doctor who examined Ms. Silva stated that she suffered from a vaccine-related injury.

The special master conducted a status conference in October 2010, wherein the parties agreed that the next step was to determine whether petitioner had a conversion disorder or a demyelinating condition. Petitioner agreed to file an expert report addressing this question. Later, petitioner’s counsel notified the special master that he would not submit the expert report; he intended to withdraw as counsel of record in the ease.3

The special master issued a decision denying compensation because of petitioner’s failure to provide a medical opinion linking her injury to the allegedly harmful vaccine. The special master denied attorneys’ fees and costs because petitioner did not demonstrate that her claim had a reasonable basis. Petitioner filed a motion for review of the fees decision.

APPLICABLE VACCINE LAW

The Vaccine Act provides that the special master or court must award attorneys’ fees and costs to petitioner if petitioner is awarded compensation on the merits. If a judgment entered by this court does not award compensation on the merits, the special master may nevertheless award fees and costs so long as the petition had a reasonable basis and it was brought in good faith.4

[403]*403Ms. Silva’s petition did not result in compensation on the merits, so she falls into the discretionary-award category for fees and costs provided for in Section B of the statute. According to Section B, the special master must make additional findings to justify awarding attorneys’ fees. These findings are whether “the petition was brought in good faith and there was a reasonable basis for the claim.” If the special master so determines, he or she may award the fees.5

THE SPECIAL MASTER’S RULING

Ms. Silva was not entitled to an award of attorneys’ fees because her claim did not have a reasonable basis. The special master reviewed the court’s historic treatment of the “reasonable basis” standard, and noted the absence of guidance or precedent for interpreting the term from this court or from the Court of Appeals for the Federal Circuit. He turned to the special masters’ own treatment of the term “reasonable basis” as it has related to attorneys’ fees over the years.

According to the special master, medical records or a medical opinion was required to find a reasonable basis for the petition in the early years of the Vaccine Act. Cases filed later, however, often days or hours before various statutes of limitation expired, were evaluated by a more lenient standard. Special masters tended to construe the standards of reasonableness to support award of attorneys’ fees even where cases failed on the merits, presumably as a matter of equity where statutory deadlines loomed.

The special master exhibited valuable research and knowledge of the Vaccine Act’s history and application, though his rationale for denying fees in the case before us seems indirect. The special master stated, “Ms. Silva’s case, however, does not need to be resolved on such sweeping grounds.6 It is sufficient to find that Ms. Silva’s case lacked a reasonable basis because her attorneys did not act reasonably. The attorneys essentially did not investigate Ms. Silva’s case properly before filing it.” Silva, 2012 WL 2890452, at *13.

The special master concluded that Ms. Silva’s case did not have a reasonable basis by examining whether her medical records supported the claim and whether her attorney’s methods were adequate. He looked first at the substance of the medical records that petitioner’s counsel possessed before filing the claim for Ms. Silva, and found that the records “cast doubt upon, rather than support, her claim.”7 Id. at *1. The special master focused on the inconclusive diagnosis of transverse myelitis (TM) when examining petitioner’s medical records. He noted that petitioner’s MRI studies were negative for transverse myelitis, which should have been a red flag for counsel.8 No doctor stated that the HPV vaccine caused petitioner to suffer transverse myelitis.

Next, the special master determined that the attorneys’ methods were “neither diligent nor adequate” because the attorneys spent very little time reviewing medical records before filing the petition. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
108 Fed. Cl. 401, 2012 U.S. Claims LEXIS 1682, 2012 WL 6789066, Counsel Stack Legal Research, https://law.counselstack.com/opinion/silva-v-secretary-of-health-human-services-uscfc-2012.